Login

Watch CNBC's full interview with Orange CEO Christel Heydemann discussing telecommunications and technology trends. 00:10:00

Share On Facebook Share On Twitter

Xavier Pichon is Chief Executive Officer at Orange Belgium. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Lee Baldwin's Future: Investing in Technology, Cybersecurity, and Long-Term Growth
00:10:00
On a Mission to Power SMBs|Graham Carney,Investor,GGV Capital
00:10:00
Parfit: A Philosopher's Quest for Moral Objectivity|David Edmonds,Professor,BBC World Service
00:10:00
Private Equity's Strategic Moves in European Financial Sector | Steve Pierson, President , Lovell Minnick Partners .
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Ministry of Future Affairs|Ashot Arzumanyan,Partner,SmartGateVC
00:10:00
strategic resources into each company throughout its lifecycle|Chris Zeoli,Partner,Wing Venture Capital
00:10:00
Overview of Murchison Minerals’ Key Projects and Targets
00:10:00
Revenues for Albert Technologies increased by over three times in 2018 | Antoine Vatar, CEO, Albert Technologies Ltd ALB:LSE
00:10:00
Gold and Silver Market Insights and Outlook for 2023
00:10:00
Hawkins Project Exploration Update: Key Findings and High-Grade Sampling Insights
00:10:00
Chinese Companies Consider Hong Kong Listings Amid US Disadvantages | Hao Hong, chief China strategist , Bank of Communications.

© 2017 - Neuhu+